- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02742922
Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) (C-MAP)
Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Suicide is a serious global public health issue, ranked amongst the leading causes of death in many countries. Most of these (75%) are in the low and middle income countries (LAMIC) and globally suicide is the second leading cause of death in young people 15-29 years of age. There is no official data on suicide from Pakistan, a conservative South Asian Islamic country with historically low suicide rates. Both suicide and attempted suicide are illegal acts, as well as socially and religiously condemned, however, there is accumulating evidence that suicide rates have been gradually increasing in Pakistan over the last few years.
The culturally adapted psychological intervention C-MAP utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice. Our previous pilot trial in Karachi shows the efficacy of CBT based intervention(C-MAP) in people who had recently self harmed.The findings from this work have highlighted the applicability of such an intervention to health services in Pakistan for patients who present after a self-harm episode
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Balochistan
-
Quetta, Balochistan, Pakistan
- Bolan Medical Complex
-
-
KPK
-
Peshawar, KPK, Pakistan
- Khyber Teaching Hospital
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Services Hospital
-
Lahore, Punjab, Pakistan
- Jinah Hospital
-
Rawalpindi, Punjab, Pakistan
- Rawalpindi General Hospital
-
-
Sind
-
Karachi, Sind, Pakistan, 72400
- Civil Hospital
-
-
Sindh
-
Karachi, Sindh, Pakistan
- Abbasi Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients over the age of 18 years will be considered eligible for the study.
- Participants will have to be living within the catchment area of the participating practices and hospitals.
- Not needing inpatient psychiatric treatment.
Exclusion Criteria:
- Temporary resident unlikely to be available for follow up.
- Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability.
- Unable to engage, participate or respond to the research questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Culturally adapted therapy (C-MAP)
Culturally adapted manual assisted (C-MAP) brief problem solving therapy
|
C-MAP is a brief problem focused therapy, comprising of six sessions delivered within three months.
C-MAP is a manual assisted intervention based on the principles of CBT .In this intervention there is an evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking and relapse prevention strategies.
Other Names:
|
|
No Intervention: Treatment as usual
This arm will receive no intervention only TAٓU.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Attempt Self Injury Interview SASII
Time Frame: up to 12th months
|
Repetition rate of self-harm measured by adapted Suicide Attempt Self-Injury Interview (SASII)
|
up to 12th months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Scale for Suicidal ideation (BSI).
Time Frame: Baseline, 3, 6, 9 and 12th months
|
This is a 19-item instrument for detecting and measuring the current intensity of the patients' specific attitudes, behaviours, and specificity of a patient's thoughts to kill him/herself during the past week.
|
Baseline, 3, 6, 9 and 12th months
|
|
Beck Hopelessness Scale
Time Frame: Baseline,3rd,6th,9th and 12th months
|
This is a 21 items scale measuring symptoms of depression.
Higher scores on the scale indicate greater severity of depression
|
Baseline,3rd,6th,9th and 12th months
|
|
Beck Depression Inventory (BDI)
Time Frame: Baseline,3rd,6th,9th and 12th months
|
This is a 21 items scale measuring symptoms of depression.
Higher scores on the scale indicate greater severity of depression
|
Baseline,3rd,6th,9th and 12th months
|
|
EuroQol-5 Dimensions (EQ5-D)
Time Frame: Baseline,3rd,6th,9th and 12th months
|
A standardised instrument to measure health status and associated population utility weights.
It consists of a self-report questionnaire covering five dimensions of health (mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression).
|
Baseline,3rd,6th,9th and 12th months
|
|
Coping Resource Inventory (CRI).
Time Frame: Baseline,3rd,6th,9th and 12th months
|
To assess the coping resources to manage stress available to an individual.
|
Baseline,3rd,6th,9th and 12th months
|
|
Client Satisfaction Questionnaire (CSQ).
Time Frame: Baseline,3rd,6th,9th and 12th months
|
The participants will rate their satisfaction with treatment by using the CSQ.
|
Baseline,3rd,6th,9th and 12th months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nusrat Husian, MD, University of Manchester
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PILL-CMAP-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.